Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Four-Year Data Shows Targeted Cryoablation Therapy Successful In Prostate Cancer ANN ARBOR, MI -- Aug. 4, 1998 -- New data on the success of temperature-based cryosurgery technology treatments for prostate cancer (also known as targeted cryoablation therapy) was presented at Prostate Cancer Symposium -- For the Patient, a national prostate cancer conference held here this weekend. The results point toward temperature monitored freezing of cancerous tissue as an exciting, durable and minimally-invasive method of successfully ridding the body of cancer. At the symposium, Fred Lee, M.D., director of prostate surgery at Crittenton Hospital in Rochester, MI., revealed newly compiled four-year data on results for targeted cryoablation treatments utilising state of the art temperature monitoring. The data was highlighted by the announcement that more than 85 percent of Dr. Lee's patients who received monitored temperature-based treatment for confined prostate cancer over the past four years (more than 580 patients) remain cancer-free (as determined by negative biopsy results). In addition, Dr. Lee announced that the PSA rates among patients receiving temperature monitored treatment were virtually undetectable (0.18 ng/ml) and that, due to the minimally invasive nature of the procedure, over 98 percent of the patients required only an overnight stay at the hospital following their cryoablation treatment. "Targeted cryoablation is the best treatment methodology available for men with prostate cancer and I've seen them all," Lee said. "I say this not only as a doctor utilising the technology to treat patients, but as a prostate cancer survivor myself." The technology being used by Lee was developed by Irvine, CA.-based Endocare, Inc. Cancer of the prostate is the second most common malignancy in men and the third most common cause of death. In the U.S., the disease afflicts approximately five million men. E-mail this page to a friend or colleague! To print, use this version